REFERENCES
- Aitken A. E., Roman L. J., Loughran P. A., de la Garza M. A., Masters B. S. S. Expressed CYP4A4 metabolism of prostaglandin E1 and arachidonic acid. Arch. Biochem. Biophys 2001; 393: 329–338, [INFOTRIEVE], [CSA]
- Aleck K. A., Bartley D. L. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am. J. Med. Genet 1997; 72: 253–256, [INFOTRIEVE], [CROSSREF], [CSA]
- Antley R. M., Bixler D. Trapezoidocephaly, midface hypoplasia and cartilage abnormalities with multiple synostoses and skeletal fractures. Birth Defects Orig. Art. Ser 1975; XI(2)397–401, [CSA]
- Aoki Y., Yoshihara F., Kondoh M., Nakamura Y., Nakayama N., Arisawa M. Ro 0-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi. Antimicrob. Agents Chemother 1993; 37: 2662–2667, [INFOTRIEVE], [CSA]
- Arlt W., Walker E. A., Draper N., lvison H. E., Ride J. P., Hammer F., Chalder S. M., Borucka-Mankiewicz M., Hauffa B. P., Malunowicz E. M., Stewart P. M., Shackleton C. H. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004; 363: 2128–2135, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Auchus R. J., Lee T. C., Miller W. L. Cytochrome b5 augments the 17,20-Lyase activity of human P450c17 without direct direct electron transfer. J. Biol. Chem 1998; 273: 3158–3165, [INFOTRIEVE], [CROSSREF], [CSA]
- Auchus R. J., Miller W. L. Molecular modeling of human P450c17 (17a-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol. Endocrinol 1999; 13: 1169–1182, [INFOTRIEVE], [CROSSREF], [CSA]
- Black S. D., French J. S., Williams C. H., Coon M. J. Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM. Biochem. Biophys. Res. Commun 1979; 91: 1528–1535, [INFOTRIEVE], [CROSSREF], [CSA]
- Bonfils C., Balny C., Maurel P. Direct evidence for electron transfer from ferrous cytochrome b5 to the oxyferrous intermediate of liver microsomal cytochrome P-450 LM2. J. Biol. Chem 1981; 256: 9457–9465, [INFOTRIEVE], [CSA]
- Bridges A., Gruenke L., Chang Y.-T., Vakser I. A., Loew G., Waskell L. Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase. J. Biol. Chem 1998; 273: 17036–17049, [INFOTRIEVE], [CROSSREF], [CSA]
- Capdevila J., Parkhill L., Chacos N., Okita R., Masters B. S., Estabrook R. W. The oxidative metabolism of arachidonic acid by purified cytochromes P-450. Biochem. Biophys. Res. Commun 1981; 101: 1357–1363, [INFOTRIEVE], [CROSSREF], [CSA]
- Chitayat D., Chun K. Reply to the letter to the editor by Gripp et al.—‘not Antley-Bixler syndrome’. (Letter). Am. J. Med. Genet 1999; 83: 67–68, [CROSSREF], [CSA]
- Chun K., Siegel-Bartelt J., Chitayat D., Phillips J., Ray P. N. FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am. J. Med. Genet 1988; 77: 219–224, [CROSSREF], [CSA]
- Cohen B., Estabrook R. W. Microsomal electron transport reactions. I. Interaction of reduced triphosphopyridne nucleotide during the oxidative demethylation of aminopyrine and cytochrome b5 reduction. Arch. Biochem. Biophys 1971a; 143: 37–45, [INFOTRIEVE], [CROSSREF], [CSA]
- Cohen B., Estabrook R. W. Microsomal electron transport reactions. II. The use of reduced triphosphopyridine nucleotide and/or reduced diphosphopyridine nucleotide for the oxidative N-demethylation of aminopyrine and other drug substrates. Arch. Biochem. Biophys 1971b; 143: 46–53, [INFOTRIEVE], [CROSSREF], [CSA]
- Cohen B., Estabrook R. W. Microsomal electron transport reactions. III. Cooperative interactions between reduced diphosphopyridine nucleotide and reduced triphosphopyridine nucleotide linked reactions. Arch. Biochem. Biophys 1971c; 143: 54–65, [INFOTRIEVE], [CROSSREF], [CSA]
- Cooper D. Y., Cannon M. D., Schleyer H., Rosenthal O. Reductive titration of cytochrome P-450 in rat liver microsomes. J. Biol. Chem 1977; 252: 4755–4757, [INFOTRIEVE], [CSA]
- Davydov D. R., Kariakin A. A., Petushkova N. A., Peterson J. A. Association of cytochromes P450 with their reductases: opposite sign of the electrostatic interactions in P450BM-3 as compared with the microsomal 2B4 system. Biochemistry 2000; 39: 6489–6497, [INFOTRIEVE], [CROSSREF], [CSA]
- DeLozier C. D., Antley R. M., Williams R., Green N., Heller R. M., Bixler D., Engel E. The syndrome of multisynostotic osteodysgenesis with long-bone fractures. Am. J. Med. Genet 1980; 7: 391–403, [INFOTRIEVE], [CROSSREF], [CSA]
- Devereux T. R., Fouts J. R. Effect of pregnancy or treatment with cetain steroids on N, N-dimethylaniline demethylation and N-oxidation by rabbit liver or lung microsomes. Drug Metab. Dispos 1975; 3: 254–258, [INFOTRIEVE], [CSA]
- Enoch H. G., Strittmatter P. Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. J. Biol. Chem 1979; 254: 8976–8981, [INFOTRIEVE], [CSA]
- Estabrook R. W., Cooper D. Y., Rosenthal O. The light-reversible carbon monoxide inhibition of the steroid C-21 hydroxylation system of the adrenal cortex. Biochem. Zeit 1963; 338: 741–755, [CSA]
- Filler R., Lew K. J. Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos. Proc. Natl. Acad. Sci. USA 1981; 78: 6991–6995, [INFOTRIEVE], [CSA]
- Fisher C. W., Shet M. S., Estabrook R. W. Construction of plasmids and expression in Escherichia coli of enzymatically active fusion proteins containing the heme-domain of a P450 linked to NADPH-P450 reductase. Methods Enzymol 1996; 272: 15–25, [INFOTRIEVE], [CSA]
- Flück C. E., Tajima T., Pandy A. V., Arlt W., Okuhara K., Verge C. F., Jabs E. W., Mendonça B. B., Fujieda K., Miller W. L. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat. Genet 2004; 36: 228–230, [CROSSREF], [CSA]
- Geller D. H., Auchus R. J., Mendonça B. B., Miller W. L. The genetic and functional basis of isolated 17,20-lyase deficiency. Nat. Genet 1997; 17: 201–205, [INFOTRIEVE], [CROSSREF], [CSA]
- Gillette J. R., Brodie B. B., La Du B. N. The oxidation of drugs by liver microsomes: on the role of TPNH and oxidase. J. Pharmacol. Exp. Ther 1957; 119: 532–540, [INFOTRIEVE], [CSA]
- Glazer R. I., Schenkman J. B., Sartorelli A. C. Immunochemical studies on the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase (P-450) reductase in drug oxidation. Mol. Pharmacol 1971; 7: 683–688, [INFOTRIEVE], [CSA]
- Gonczy P., Echeverri C., Oegema K., Coulson A., Jones S. J., Copley R. R., Duperon J., Oegema J., Brehm M., Cassin E., Hannak E., Kirkham M., Pichler S., Flohrs K., Goessen A., Leidel S., Alleaume A. M., Martin C., Ozlu N., Bork P., Hyman A. A. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 2000; 408: 331–336, [INFOTRIEVE], [CROSSREF], [CSA]
- Guengerich F. P. Human cytochrome P450 enzymes. Cytochrome P450 Structure, Mechanism and Biochemistry 3rd, P. R. Ortiz de Montellano. Kluwer Academic/Plenum Publishers, New York 2005; 377–530
- Hasemann C. A., Kurumbail R. G., Boddupalli S. S., Peterson J. A., Deisenhofer J. Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 1995; 3: 41–62, [INFOTRIEVE], [CROSSREF], [CSA]
- Henderson C. J., Otto D. M., Carrie D., Magnuson M. A., McLaren A. W., Rosewell I., Wolf C. R. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem 2003; 278: 13480–13486, [INFOTRIEVE], [CROSSREF], [CSA]
- Hildebrandt A., Estabrook R. W. Evidence for the participation of cytochrome b5 in hepatic microsomal mixed-function oxidation reactions. Arch. Biochem. Biophys 1971; 143: 66–79, [INFOTRIEVE], [CROSSREF], [CSA]
- Hlavica P. On the function of cytochrome b5 in the cytochrome P-450-dependent oxygenase system. Arch. Biochem. Biophys 1984; 228: 600–608, [INFOTRIEVE], [CROSSREF], [CSA]
- Hosny G., Roman L. J., Mostafa M. H., Masters B. S. S. Characterization of purified, E. coli-expressed cytochrome P450 4A5. Arch. Biochem. Biophys 1999; 366: 199–206, [INFOTRIEVE], [CROSSREF], [CSA]
- Huang N., Pandey A. V., Agrawal V., Reardon W., Lapunzina P. D., Mowat D., Jabs E. W., Vliet G. V., Sack J., Flück C. E., Miller W. L. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am. J. Hum. Genet 2005; 76: 729–749, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hubbard P. A., Shen A. L., Paschke R., Kasper C. B., Kim J. J. NADPH-cytochrome P450 oxidoreductase. Structural basis for hydride and electron transfer. J. Biol. Chem 2001; 276: 29163–29170, [INFOTRIEVE], [CROSSREF], [CSA]
- Imai Y., Sato R. The roles of cytochrome b5 in a reconstituted N-demethylase system containing cytochrome P450. Biochem. Biophys. Res. Commun 1977; 75: 420–426, [INFOTRIEVE], [CROSSREF], [CSA]
- Ingelman-Sundberg M., Johansson I. Cytochrome b5 as electron donor to rabbit liver cytochrome P-450LM2 in reconstituted phospholipid vesicles. Biochem. Biophys. Res. Commun 1980; 97: 582–586, [INFOTRIEVE], [CROSSREF], [CSA]
- Jansson I., Schenkman J. B. Substrate influence on interaction between cytochrome P450 and cytochrome b5 in microsomes. Arch. Biochem. Biophys 1996; 325: 265–269, [INFOTRIEVE], [CROSSREF], [CSA]
- Johnson E. F., Walker D. L., Griffin K. J., Clark J. E., Okita R. T., Muerhoff A. S., Masters B. S. S. Cloning and expression of three rabbit kidney cDNAs encoding lauric acid ω‐hydroxylases. Biochemistry 1990; 29: 873–879, [INFOTRIEVE], [CROSSREF], [CSA]
- Karplus P. A., Daniels M. J., Herriot J. R. Atomic structure of ferredoxin-NADP+ reductase: prototype for a structurally novel flavoenzyme family. Science 1991; 251: 60–66, [INFOTRIEVE], [CSA]
- Kasper C. B. Biochemical distinctions between the nuclear and microsomal membranes from rat hepatocytes. J. Biol. Chem 1971; 246: 577–581, [INFOTRIEVE], [CSA]
- Katagiri M., Kagawa N., Waterman M. R. The role of cytochrome b5 in the biosynthesis of androgens by human CYP17. Arch. Biochem. Biophys 1995; 317: 343–347, [INFOTRIEVE], [CROSSREF], [CSA]
- Kelley R. I., Kratz L. E., Glaser R. L., Netzloff M. L., Wolf L. M., Jabs E. W. Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. Am. J. Med. Genet 2002; 110: 95–102, [INFOTRIEVE], [CROSSREF], [CSA]
- Kondo S., Sakaki T., Ohkawa H., Inouye K. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase. Biochem. Biophys. Res. Commun 1999; 257: 273–278, [INFOTRIEVE], [CROSSREF], [CSA]
- Kupfer D., Miranda G. K., Navarro J., Piccolo D. E., Theoharides A. D. Effect of inducers and inhibitors of monooxygenase on the hydroxylation of prostaglandins in the guinea pig. Evidence for several monooxygenases catalyzing ω- and (ω-1)-hydroxylation. J. Biol. Chem 1979; 254: 10405–10414, [INFOTRIEVE], [CSA]
- Kupfer D., Navarro J., Miranda G. K., Theoharides A. D. Metabolism of prostaglandins and xenobiotics by adrenal microsomal monooxygenase in the guinea pig. Arch. Biochem. Biophys 1980; 205: 297–307, [INFOTRIEVE], [CROSSREF], [CSA]
- Kupfer D., Navarro J., Piccolo D. E. Hydroxylation of prostaglandins A1 and E1 by liver microsomal monooxygenase. Characteristics of the enzyme system in the guinea pig. J. Biol. Chem 1978; 253: 2804–2811, [INFOTRIEVE], [CSA]
- Kuriyama Y., Omura T., Siekevitz P., Palade G. Effects of phenobarbital on the synthesis and degradation of the protein components of rat liver microsomal membranes. J. Biol. Chem 1969; 244: 2017–2026, [INFOTRIEVE], [CSA]
- La Du B. N., Gaudette L., Trousof N., Brodie B. B. Enzymatic dealkylation of aminopyrine (Pyramidon) and other alkylamines. J. Biol. Chem 1955; 214: 741–752, [INFOTRIEVE], [CSA]
- Lamb D. C., Kelly D. E., Manning N. J., Kaderbhai M. A., Kelly S. L. Biodiversity of the P450 catalytic cycle: yeast cytochrome b5/NADH cytochrome b5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction. FEBS Lett 1999; 462: 283–288, [INFOTRIEVE], [CSA]
- Lee-Robichaud P., Kaderbhai M., Kaderbhai N., Wright J. N., Akhtar M. Interaction of human CYP17 (P-45017α, 17α-hydroxylase-17,20-lyase) with cytochrome b5: Importance of the orientation of the hydrophobic domain of cytochrome b5. Biochem. J 1997; 321: 857–863, [INFOTRIEVE], [CSA]
- Lee-Robichaud P., Wright J. N., Akhtar M. E., Akhtar M. Modulation of the activity of human 17α-hyroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications. Biochem. J 1995; 308: 901–908, [INFOTRIEVE], [CSA]
- Lipka J. J., Waskell L. A. Methoxyflurane acts at the substrate binding site of cytochrome P450 LM2 to induce a dependence on cytochrome b5. Arch. Biochem. Biophys 1989; 268: 152–160, [INFOTRIEVE], [CROSSREF], [CSA]
- Loughran P. A., Roman L. J., Aitken A. E., Miller R. T., Masters B. S. S. Identification of unique amino acids that modulate CYP4A7 activity. Biochemistry 2000; 39: 15110–15120, [INFOTRIEVE], [CROSSREF], [CSA]
- Loughran P. A., Roman L. J., Miller R. T., Masters B. S. S. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: Cytochrome b5 effects vary with substrate. Arch. Biochem. Biophys 2001; 385: 311–321, [INFOTRIEVE], [CROSSREF], [CSA]
- Lu A. Y. H., Coon M. J. Role of hemoprotein P-450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem 1968; 243: 1331–1332, [INFOTRIEVE], [CSA]
- Lu A. Y. H., Levin W., Selander H., Jerina D. M. Liver microsomal electron transport systems. III. The involvement of cytochrome b5 in the NADPH-supported cytochrome P-450-dependent hydroxylation of chlorobenzene. Biochem. Biophys. Res. Commun 1974; 61: 1348–1355, [INFOTRIEVE], [CROSSREF], [CSA]
- Marx J. L. The cytochrome P450's and their genes. Science 1995; 228: 975–976, [CSA]
- Masters B. S. S., Baron J., Taylor W. E., Isaacson E. L., LoSpalluto J. Immunochemical studies on electron transport chains involving cytochrome P-450. I. Effects of antibodies to pig liver microsomal reduced triphosphopyridine nucleotide-cytochrome c reductase and the non-heme iron protein from bovine adrenocortical mitochondria. J. Biol. Chem 1971a; 246: 4143–4150, [INFOTRIEVE], [CSA]
- Masters B. S. S., Nelson E. B., Ziegler D. M., Baron J., Raj P. P., Isaacson E. L. Immunochemical studies utilizing antibody to NADPH-cytochrome c reductase as a specific inhibitor of microsomal electron transport. Chem. Biol. Interact 1971b; 3: 607–613, [CSA]
- Okita R. T., Parkhill L. K., Yasukochi Y., Masters B. S. S., Theoharides A. D., Kupfer D. The ω- and (ω-1)-hydroxylase activities of prostaglandins A1 and E1 and lauric acid by pig kidney microsomes and a purified kidney cytochrome P-450. J. Biol. Chem 1981; 256: 5961–5964, [INFOTRIEVE], [CSA]
- Omura T., Sato R. A new cytochrome in liver microsomes. J. Biol. Chem 1962; 237: 1375–1381, [INFOTRIEVE], [CSA]
- Otto D. M., Henderson C. J., Carrie D., Davey M., Gunderson T. E., Blomhoff R., Adams R. H., Tickle C., Wolf C. R. Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol. Cell. Biol 2003; 23: 6103–6116, [INFOTRIEVE], [CROSSREF], [CSA]
- Peterson J. A., White R. E., Yasukochi Y., Coomes M. L., O'Keeffe D. H., Ebel R. E., Masters B. S. S., Ballou D. P., Coon M. J. Evidence that purified liver microsomal cytochrome P450 is a one-electron acceptor. J. Biol. Chem 1977; 252: 4431–4434, [INFOTRIEVE], [CSA]
- Phillips A. H., Langdon R. G. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: Isolation, characterization, and kinetic studies. J. Biol. Chem 1962; 237: 2652–2660, [INFOTRIEVE], [CSA]
- Powell W. S. ω-Oxidation of prostaglandins by lung and liver microsomes. Changes in enzyme activity induced by pregnancy, pseudopregnancy, and progesterone treatment. J. Biol. Chem 1978; 253: 6711–6716, [INFOTRIEVE], [CSA]
- Powell W. S., Solomon S. Formation of 20-hydroxyprostaglandins by lungs of pregnant rabbits. J. Biol. Chem 1978; 253: 4609–4616, [INFOTRIEVE], [CSA]
- Pursley T. J., Blomquist I. K., Abraham J., Andersen H. F., Bartley J. A. Fluconazole-induced congenital anomalies in three infants. Clin. Infect. Dis 1996; 22: 336–340, [INFOTRIEVE], [CSA]
- Reardon W., Smith A., Honour J. W., Hindmarsh P., Das D., Rumsby G., Nelson I., Malcolm S., Ades L., Sillence D., Kumar D., DeLozier-Blanchet C., McKee S., Kelly T., McKeehan W. L., Baraitser M., Winter R. M. J. Med. Genet 2000; 37: 26–32, [INFOTRIEVE], [CROSSREF], [CSA]
- Roman L. J., Palmer C. N. A., Clark J. E., Muerhoff A. S., Griffin K. J., Johnson E. F., Masters B. S. S. Expression of rabbit cytochromes P4504A which catalyze the ω‐hydroxylation of arachidonic acid, fatty acids and prostaglandins. Arch. Biochem. Biophys 1993; 307: 57–65, [INFOTRIEVE], [CROSSREF], [CSA]
- Rossmann M. G., Moras D., Olsen K. W. Chemical and biological evolution of nucleotide-binding proteins. Nature 1974; 250: 194–199, [INFOTRIEVE], [CROSSREF], [CSA]
- Sasame H. A., Thorgeirsson S. S., Mitchell J. R., Gillette J. R. The possible involvement of cytochrome b5 in the oxidation of lauric acid by microsomes from kidney cortex and liver of rats. Life Sci 1974; 14: 35–46, [INFOTRIEVE], [CROSSREF], [CSA]
- Sasame H. A., Thorgeirsson S. S., Mitchell J. R., Gillette J. R. The role of cytochrome b5 in cytochrome P-450 enzymes. Adv. Exp. Med. Biol 1975; 58: 435–445, [INFOTRIEVE], [CSA]
- Schachter B. A., Nelson E. B., Marver H. S., Masters B. S. S. Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. J. Biol. Chem 1972; 247: 3601–3607, [CSA]
- Schinzel A., Savoldelli G., Briner J., Sigg P., Massini C. Antley-Bixler syndrome in sisters: a term newborn and a prenatally diagnosed fetus. Am. J. Med. Genet 1983; 14: 139–147, [INFOTRIEVE], [CROSSREF], [CSA]
- Serabjit-Singh C. J., Albro P. W., Robertson I. G. C., Philpot R. M. Interactions between xenobiotics that increase or decrease the levels of cytochrome P-450 isozymes in rabbit lung and liver. J. Biol. Chem 1983; 258: 12827–12834, [INFOTRIEVE], [CSA]
- Shen A. L., Kasper C. B. Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome. c. J. Biol. Chem 1995; 270: 27475–27480, [CSA]
- Shen A. L., O'Leary K. A., Kasper C. B. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem 2002; 277: 6536–6541, [INFOTRIEVE], [CROSSREF], [CSA]
- Strobel H. W., Lu A. Y. H., Heidema J., Coon M. J. Phosphatidylcholine requirement in the enzymatic reduction of hemoprotein P-450 and in fatty acid, hydrocarbon, and drug hydroxylation. J. Biol. Chem 1970; 245: 4851–4854, [INFOTRIEVE], [CSA]
- Stromstedt M., Keeney D. S., Waterman M. R., Paria B. C., Conley A. J., Dey S. K. Preimplantation mouse blastocysts fail to express CYP genes required for estrogen biosynthesis. Mol. Reprod. Dev 1996; 43: 428–436, [INFOTRIEVE], [CROSSREF], [CSA]
- Suzuki K., Kanda Y., Sugiyama K., Katoh T., Wada Y., Yasui Y. Antley-Bixler syndrome in a sister and brother. Jpn. J. Hum. Genet 1987; 32: 247–252, [CROSSREF], [CSA]
- Truan G., Epinat J. C., Rougeulle C., Cullin C., Pompon D. Cloning and characterization of a yeast cytochrome b5-encoding gene which suppresses ketoconazole hypersensitivity in a NADPH-P-450 reductase-deficient strain. Gene 1994; 142: 123–127, [INFOTRIEVE], [CROSSREF], [CSA]
- Vatsis K. P., Theoharides A. D., Kupfer D., Coon M. J. Hydroxylation of prostaglandins by inducible isozymes of rabbit liver microsomal cytochrome P-450. Participation of cytochrome b5. J. Biol. Chem 1982; 257: 11221–11229, [INFOTRIEVE], [CSA]
- Wada F., Shibata H., Goto M., Sakamoto Y. Participation of the microsomal electraon transport system involving cytochrome P-450 in ω-oxidation of fatty acids. Biochim. Biophys. Acta 1968; 162: 518–524, [INFOTRIEVE], [CROSSREF], [CSA]
- Wang M., Roberts D. L., Paschke R., Shea T. M., Masters B. S. S., Kim J. J. P. Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for FMN- and FAD-containing enzymes. Proc. Nat. Acad. Sci. USA 1997; 94: 8411–8416, [INFOTRIEVE], [CROSSREF], [CSA]
- Waskell L. A., Vigne J. L., Vergeres G. Site of action of substrates requiring cytochrome b5 for oxidation by cytochrome P450. Methods in Enzymology 1991; 206: 523–529, [INFOTRIEVE], [CSA]
- Werringloer J., Kawano S. Cytochrome b5 and the integrated microsomal electron transport system. Microsomes, Drug Oxidations, and Chemical Carcinogenesis, M. J. Coon, A. W. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette, P. J. O'Brien. Academic Press, New York 1980; 469–476, Vol. 1
- West S. B., Levin W., Ryan D., Vore M., Lu A. Y. H. Liver microsomal electron transport systems. II. The involvement of cytochrome b5 in the NADH-dependent hydroxylation of 3,4-benzpyrene by a reconstituted cytochrome P-448-containing system. Biochem. Biophys. Res. Commun 1974; 58: 516–522, [INFOTRIEVE], [CROSSREF], [CSA]
- Williams C. H., Jr., Kamin H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J. Biol. Chem 1962; 237: 587–595, [INFOTRIEVE], [CSA]
- Williams D. E., Hale S. E., Okita R. T., Masters B. S. S. A prostaglandin ω-hydroxylase cytochrome P-450 (P-450PG-ω) purified from lungs of pregnant rabbits. J. Biol. Chem 1984; 259: 14600–14608, [INFOTRIEVE], [CSA]
- Wu L., Gu J., Cui H., Zhang Q.-Y., Behr M., Fang C., Weng Y., Kluetzman K., Swiatek P. J., Yang W., Kaminskey L., Ding X. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450. J. Pharmacol. Exp. Ther 2005; 312: 35–43, [INFOTRIEVE], [CROSSREF], [CSA]
- Wu L., Gu J., Weng Y., Kluetzman K., Swiatek P., Behr M., Zhang Q. Y., Zhuo X., Xie Q., Ding X. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene. Genesis 2003; 36: 177–181, [INFOTRIEVE], [CROSSREF], [CSA]
- Yamamoto S., Kusunose E., Ogita K., Kaku M., Ichihara K., Kusunose M. Isolation of cytochrome P-450 highly active in prostaglandin omega-hydroxylation from lung microsomes of rabbits treated with progesterone. J. Biochem 1984; 96: 593–603, [INFOTRIEVE], [CSA]
- Yamazaki H., Johnson W. W., Ueng Y.-F., Shimada T., Guengerich F. P. Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5. J. Biol. Chem 1996a; 271: 27438–27444, [INFOTRIEVE], [CROSSREF], [CSA]
- Yamazaki H., Nakano M., Imai Y., Ueng Y.-F., Guengerich F. P., Shimada T. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Arch. Biochem. Biophys 1996b; 325: 174–182, [INFOTRIEVE], [CROSSREF], [CSA]
- Yasui Y., Yamaguchi A., Itoh Y., Ueke T., Sugiyama K., Wada Y. The first case of the Antley-Bixler syndrome with consanguinity in Japan. Jpn. J. Hum. Genet 1983; 28: 215, [CROSSREF], [CSA]